OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Albert Einstein College of Medicine

3 Projects | 3 Researchers | $682,367 Invested

2026

Albert Einstein College of Medicine

Thomas Leyh, Phd

Small Molecule Prevention of Alzheimer’s Disease

  • Funding Amount: $518,313
  • Organization Type:
  • Program: Drug Discovery
  • Target: ApoE, Lipids and Lipoprotein Receptors
  • Status: Active

2014

Albert Einstein College of Medicine

Steven Walkley, DVM, PhD

2015 Lysosomal Diseases Gordon Research Conference and Gordon Research Seminar

  • Funding Amount: $3,000
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2006

Albert Einstein College of Medicine

Luciano D'Adamio, MD, PhD

Optimization of GSK-3Beta Inhibitors as multipotent regulators of Tau and APP.

  • Funding Amount: $161,054
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed